Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and …
K Fujita, S Yazumi, H Matsumoto, M Asada… - Digestive …, 2022 - Wiley Online Library
Objectives The reported incidence of adverse events (AEs) in endoscopic retrograde
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and …
K Fujita, S Yazumi, H Matsumoto, M Asada… - … : Official Journal of the …, 2022 - europepmc.org
Objectives The reported incidence of adverse events (AEs) in endoscopic retrograde
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and …
K Fujita, S Yazumi, H Matsumoto, M Asada… - Digestive …, 2022 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objectives</jats: title>< jats: p> The reported incidence of
adverse events (AEs) in endoscopic retrograde cholangiopancreatography (ERCP) varies …
adverse events (AEs) in endoscopic retrograde cholangiopancreatography (ERCP) varies …
Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and …
K Fujita, S Yazumi, H Matsumoto… - … : official journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives The reported incidence of adverse events (AEs) in endoscopic retrograde
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
[HTML][HTML] Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events …
K Fujita, S Yazumi, H Matsumoto, M Asada… - Digestive …, 2022 - ncbi.nlm.nih.gov
Objectives The reported incidence of adverse events (AEs) in endoscopic retrograde
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
[PDF][PDF] Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events …
K Fujita, S Yazumi, H Matsumoto, M Asada, H Nebiki… - 2021 - researchgate.net
Objectives: The reported incidence of adverse events (AEs) in endoscopic retrograde
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
Multicenter prospective cohort study of adverse events associated with biliary endoscopic retrograde cholangiopancreatography: Incidence of adverse events and …
K Fujita, S Yazumi, H Matsumoto… - Digestive …, 2022 - search.ebscohost.com
Objectives: The reported incidence of adverse events (AEs) in endoscopic retrograde
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …
cholangiopancreatography (ERCP) varies between 2.5% and 14%. The aim of this study …